DR-1002 treated human dental pulp stem cells replicate 1
Commercially available human dental pulp stem cells obtained from Lonza and treated with DR-1002 at 50 ug/mL for 24 h, biological replicate 1. Total RNA was used for mRNA sequencing after Oligo(dT)-based poly(A)+ mRNA enrichment. Libraries were sequenced using paired-end 150 bp reads.